Physiologically Based in Silico Models for the Prediction of Oral Drug Absorption
暂无分享,去创建一个
[1] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[2] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[3] Anne Hersey,et al. Rate-Limited Steps of Human Oral Absorption and QSAR Studies , 2002, Pharmaceutical Research.
[4] Lawrence X. Yu,et al. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. , 2004, Current opinion in drug discovery & development.
[5] G. Grass,et al. Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.
[6] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[7] Hans Lennernäs,et al. Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.
[8] S. Nylander,et al. Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.
[9] Jörg Lippert,et al. From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools , 2005, Expert opinion on drug metabolism & toxicology.
[10] Gilles Klopman,et al. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] Thomas J. Vidmar,et al. Predicting Drug Absorption: How Nature Made It a Difficult Problem , 2002, Journal of Pharmacology and Experimental Therapeutics.
[12] G. Amidon,et al. Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.
[13] Anette Müllertz,et al. A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids , 2000, Pharmaceutical Research.
[14] Anette Müllertz,et al. Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids , 2000, Pharmaceutical Research.
[15] Christos Reppas,et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.
[16] G L Amidon,et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. , 1996, Advanced drug delivery reviews.
[17] W. Curatolo,et al. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings , 1998 .
[18] Joe Palandra,et al. Predicting Oral Absorption of Drugs: A Case Study with a Novel Class of Antimicrobial Agents , 2003, Pharmaceutical Research.
[19] Lawrence X. Yu,et al. Characterization of small intestinal transit time distribution in humans , 1998 .
[20] Anand Balakrishnan,et al. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. , 2004, Journal of pharmaceutical sciences.
[21] K. Higaki,et al. Prediction of the Plasma Concentration Profiles of Orally Administered Drugs in Rats on the Basis of Gastrointestinal Transit Kinetics and Absorbability , 1997, The Journal of pharmacy and pharmacology.
[22] Lawrence X. Yu. An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.
[23] Gordon L. Amidon,et al. Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.
[24] Christel A. S. Bergström,et al. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. , 2005, Basic & clinical pharmacology & toxicology.
[25] Anne Hersey,et al. Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. , 2003, European journal of medicinal chemistry.
[26] A. Beresford,et al. ADME/PK as part of a rational approach to drug discovery. , 2000, Drug discovery today.
[27] Patrick J. Sinko,et al. Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.
[28] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[29] W. Schmitt,et al. A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.
[30] W. Tong,et al. Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.
[31] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[32] Kevin C. Johnson,et al. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.
[33] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[34] P J Sinko,et al. Development of predictive pharmacokinetic simulation models for drug discovery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[35] Thierry Lavé,et al. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[36] Lawrence X. Yu,et al. Predicting Oral Drug Absorption in Humans , 1999 .
[37] J. Dressman,et al. Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.
[38] Gordon L Amidon,et al. Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions , 2005, Drug development and industrial pharmacy.
[39] Paul W. Buehler,et al. Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and Human , 2002, Pharmaceutical Research.
[40] A. Barve,et al. Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.
[41] H Lennernäs,et al. Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.
[42] W. L. Chiou,et al. Similarity in the linear and non-linear oral absorption of drugs between human and rat. , 2000, International journal of clinical pharmacology and therapeutics.
[43] P Langguth,et al. Intestinal drug efflux: formulation and food effects. , 2001, Advanced drug delivery reviews.
[44] Walter Schmitt,et al. A physiological model for the estimation of the fraction dose absorbed in humans. , 2004, Journal of medicinal chemistry.
[45] Lawrence X. Yu,et al. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .
[46] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[47] Elizabeth M. Topp,et al. Transport processes in pharmaceutical systems , 1999 .
[48] R. J. Hintz,et al. The effect of particle size distribution on dissolution rate and oral absorption , 1989 .
[49] G L Amidon,et al. A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.
[50] Gordon L Amidon,et al. A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.
[51] Kazutaka Higaki,et al. Gastrointestinal transit and drug absorption. , 2000, Biological & pharmaceutical bulletin.
[52] Kevin C. Johnson,et al. Dissolution and Absorption Modeling: Model Expansion to Simulate the Effects of Precipitation, Water Absorption, Longitudinally Changing Intestinal Permeability, and Controlled Release on Drug Absorption , 2003, Drug development and industrial pharmacy.
[53] Kevin C. Johnson,et al. Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.
[54] G. Grass,et al. Simulation models to predict oral drug absorption from in vitro data , 1997 .
[55] G L Amidon,et al. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[56] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[57] H Lennernäs,et al. Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.
[58] Kjell Johnson,et al. Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery. , 2004, International journal of pharmaceutics.
[59] Michael B. Bolger,et al. The composite solubility versus pH profile and its role in intestinal absorption prediction , 2008, AAPS PharmSci.
[60] J. Votano,et al. Recent uses of topological indices in the development of in silico ADMET models. , 2005, Current opinion in drug discovery & development.
[61] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[62] Hyunyoung Jeong,et al. Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans , 2000, Pharmaceutical Research.